Aplaviroc (AK 602) is a CCR5 Antagonist
Aplaviroc (AK 602), an SDP derivative, is a potent CCR5 antagonist. Additionally, the IC50s are 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL, and HIV-1MOKW. In vitro, Aplaviroc exerts potent activity against HIV-1 strains.…